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One sentence summary: This review summarizes new insights into the genetics and function of rhamnose-containing cell wall polysaccharides




The composition of the Gram-positive cell wall is typically described as containing peptidoglycan, proteins and essential
secondary cell wall structures called teichoic acids, which comprise approximately half of the cell wall mass. The cell walls
of many species within the genera Streptococcus, Enterococcus and Lactococcus contain large amounts of the sugar rhamnose,
which is incorporated in cell wall-anchored polysaccharides (CWP) that possibly function as homologues of well-studied
wall teichoic acids (WTA). The presence and chemical structure of many rhamnose-containing cell wall polysaccharides
(RhaCWP) has sometimes been known for decades. In contrast to WTA, insight into the biosynthesis and functional role of
RhaCWP has been lacking. Recent studies in human streptococcal and enterococcal pathogens have highlighted critical
roles for these complex polysaccharides in bacterial cell wall architecture and pathogenesis. In this review, we provide an
overview of the RhaCWP with regards to their biosynthesis, genetics and biological function in species most relevant to
human health. We also briely discuss how increased knowledge in this ield can provide interesting leads for new
therapeutic compounds and improve biotechnological applications.
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INTRODUCTION
The composition of the bacterial cell wall is critical for fun-
damental features such as bacterial cell shape, protection
from and interaction with the environment. Carbohydrates are
the most abundant molecules in the Gram-positive cell wall
with much of it incorporated in the thick layer of peptido-
glycan (15–100 nm) that surrounds the cell membrane (Sil-
havy, Kahne and Walker 2010). Peptidoglycan is composed of
alternating β-1,4-linked N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc) polysaccharide strands that are
cross-linked by short peptides to form a three-dimensional net-
work. Individual species tailor important physical properties of
their peptidoglycan such as elasticity and porosity through the
composition of the peptide bridge, the amount of crosslinking
and chemical modiications of the composing glycan residues
(Vollmer, Blanot and de Pedro 2008; Vollmer and Seligman 2010).
Peptidoglycan also acts as a scaffold for other critical cell wall
structures. For example, proteins containing LPXTG amino acid
motifs are covalently attached to the peptidoglycan peptide
bridge through the enzymatic action of sortase A (Hendrickx
et al. 2011).
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Cell wall polysaccharides (CWP), such as capsular polysac-
charides and wall teichoic acids (WTA), are anchored to peptido-
glycan GlcNAc or MurNAc, covering the bacterium with a layer
of glycans that is directly exposed to the environment (Deng
et al. 2000; Swoboda et al. 2010; Yother 2011). The predominance
of capsulated species among bacterial pathogens instigated
studies on the role of capsular polysaccharides in infectious dis-
ease pathogenesis. As a result, effective capsule polysaccharide
conjugate vaccines were developed against various species in-
cluding Neisseria meningitidis, Haemophilus inluenzae type B and
Streptococcus pneumoniae. For some human bacterial pathogens,
such as Staphylococcus aureus and Streptococcus pyogenes, the role
of polysaccharide capsule in pathogenesis is less pronounced
(O’Riordan and Lee 2004; Flores et al. 2012). In addition, the dis-
covery of host pattern-recognition receptors with speciicity for
carbohydrates as well as technological advances in the area of
complex carbohydrate analysis and synthesis have fueled initia-
tives to investigate bacterial glycobiologymore comprehensively
by unraveling the structure, biosynthesis and functions of bac-
terial polysaccharide structures.
In this review, we focus on a subclass of secondary CWP
that we refer to as rhamnose-containing CWP (RhaCWP). L-
rhamnose is commonly found in bacteria but is not used or pro-
duced by humans (Maki and Renkonen 2004; Adibekian et al.
2011). Interestingly, L-rhamnose is often essential for bacterial
virulence or even viability (Maki and Renkonen 2004), making its
biosynthesis pathway an attractive therapeutic target. We will
therefore review the current knowledge regarding L-rhamnose
biosynthesis and functions in bacteria in more detail. Recent
insights into the genetic basis and function of RhaCWP in two
important human pathogens, S. pyogenes (Group A Streptococ-
cus) and Streptococcus agalactiae (Group B Streptococcus), have em-
phasized the critical role of these molecules in cell wall bio-
genesis and pathogenesis (Caliot et al. 2012; van Sorge et al.
2014). This functional information combined with the localiza-
tion and abundance of RhaCWP suggests that parallels can be
drawn with WTA in other Gram-positive bacteria. WTA struc-
ture and function have been reviewed extensively (Weidenmaier
and Peschel 2008; Swoboda et al. 2010; Brown, Santa Maria and
Walker 2013). Therefore, we will only highlight speciic parallels
withWTA biology throughout this review. Finally, from their his-
toric discovery (Lanceield 1933) and recent insight from bacte-
rial genome sequences, it is apparent that RhaCWP are likely
more widespread in Gram-positive cocci within the order Lacto-
bacillales. We will provide an overview of their inferred distribu-
tion and review the literature for selected species with regard
to structure, genetics, biosynthesis and function. We will end by
discussing the potential therapeutic and biotechnological appli-
cations of this important class of CWP.
Non-classical CWP in Gram-positive cocci: a historical
perspective
Most knowledge regarding the architecture and biology of the
Gram-positive cell wall is derived from the model organisms
Bacillus subtilis and S. aureus. For these and other species, WTA
is a major cell wall component representing up to 60% of
the total cell wall mass. WTA are anionic glycopolymers that
are covalently attached to the peptidoglycan MurNAc residue
(Swoboda et al. 2010). Most commonly, WTA are composed
of a poly-ribitolphosphate (-RboP)- or poly-glycerolphosphate
(-GroP-) backbone with modiications such as glycosylation and
D-alanylation, the latter of which can neutralize the negative
charge of the abundant phosphates in the WTA backbone
(Brown, Santa Maria and Walker 2013). However, the exact
chemical composition varies among and even within species
(Neuhaus and Baddiley 2003; Weidenmaier and Peschel 2008;
Winstel, Xia and Peschel 2014). It has long been recognized
that not all Gram-positive bacteria incorporate polyRboP- or
a polyGroP-based WTA into their cell wall. Instead, the cell
walls of many species within the order Lactobacillales contain
peptidoglycan-anchored polysaccharides that are characterized
by the presence of L-rhamnose. Probably the irst reports of
RhaCWP in the genus Streptococcus date back to the late 1920s
and early 1930s by Rebecca Lanceield (Lanceield 1928a,b,
1933). Her seminal work enabled the development of a new
streptococcal classiication system—in addition to hemolytic
typing—based on the differential antigenic properties of strep-
tococcal CWP, referred to as ‘C-substance’ or ‘Group Antigen’
(Lanceield 1933). The streptococcal serotyping scheme initially
only discriminated Group A–E streptococci but was expanded to
comprise as many as 20 serotypes called Groups A–V (excluding
I and J) (Facklam 2002; Kohler 2007). The Lanceield typing
system has been instrumental to link mild and severe human
and animal diseases to speciic bacterial groups within the
genus Streptococcus, most notably S. pyogenes, causing more
than 700 million infections resulting in over 500 000 deaths
worldwide annually (Carapetis et al. 2005), and S. agalactiae, a
pathogen affecting mainly neonates and the elderly (Phares
et al. 2008; Edmond et al. 2012). Furthermore, the Lanceield
typing scheme enabled the development of rapid diagnostic
tests that aided clinically relevant ‘species identiication’ (Lue,
Howit and Ellner 1978). Increased recognition of additional
strain characteristics, such as nutrient requirements and later
the use of 16S rRNA for classiication (and more recently whole
genome sequencing), demonstrate that the Lanceield typing
system cannot discriminate to the species level such that a
single Lanceield Group represents one species. For example, the
Group A antigen was long thought to be the exclusive molecular
marker of S. pyogenes, yet Streptococcus castoreus is also noted
to react with Group A antisera in commercial diagnostic kits
(Lawson et al. 2005). Vice versa, a single species can express
different Group antigens; strains of Streptococcus dysgalactiae
subsp. equisimilis commonly express either the Group C or G
antigen (Broyles et al. 2009; McMillan et al. 2010a; Takahashi,
Ubukata and Watanabe 2011) and occasionally Group A car-
rying S. dysgalactiae subsp. equisimilis strains are identiied
(Tanaka et al. 2008; McMillan et al. 2010b). Consequently, the
taxonomy and nomenclature of the genus Streptococcus has
been reevaluated and reclassiied over the years (Facklam 2002;
Kohler 2007). This resulted in the split of the genus Streptococcus
into three genera, i.e. Enterococcus, Lactococcus and Streptococ-
cus (Schleifer et al. 1985), as well as subsequent description
of several novel members within these genera. Two species
covered in this review, Enterococcus faecalis and Lactococcus
lactis, were formerly known as Streptococcus faecalis (Lanceield
Group D) and Streptococcus lactis (Lanceield Group N). Today,
more than 150 different species are known within these three
genera, which remain classiied within the order Lactobacillales
(http://www.bacterio.net/-classifphyla.html#Firmicutes; Price
et al. 2012).
Although the direct correlation between Lanceield serotyp-
ing and species clearly no longer persists, bioinformatic anal-
yses of genome sequences indicates that many of the species
within these three genera express RhaCWP (see section ‘Dis-
tribution of RhaCWP throughout bacteria’). We focus here on the
species relevant to food production and human health and with
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Figure 1. Cell division and separation defects caused by RhaCWP deiciency in
S. mutans and S. pyogenes. Representative scanning electron microscopy images
of S. pyogenes and S. mutans wild-type (WT) strains and corresponding RhaCWP-
deicient strains. In S. pyogenes loss of the GAC was enforced by inducible knock-
out of gacA (rmlD homologue) and in S. mutans, deletion of rmlD results in loss of
RhaCWP (van der Beek et al. 2015). Scale bar is indicated in image.
experimental evidence for the presence of RhaCWP: Lanceield
Groups A, B, C, E and G Streptococcus represented by S. pyogenes,
S. agalactiae, Streptococcus equi subsp. zooepidemicus, Streptococcus
mutans and S. dysgalactiae subsp. equisimilis, respectively, as well
as E. faecalis and L. lactis.
Cell wall organization of RhaCWP
The RhaCWP is a major component in streptococcal species
comprising about 40%–60% of the cell wall by weight (McCarty
1952; Krause and McCarty 1962a; Krause 1963; Doran and Mat-
tingly 1982). Correspondingly, cell wall thickness is visually
reduced by 40%–50% after chemical extraction of the Group-
speciic carbohydrate (Swanson and Gotschlich 1973; Wagner
and Wagner 1978). Recent mutagenesis studies conirmed the
structural importance of streptococcal group antigens; complete
loss of RhaCWP expression resulted in severe growth and cell
division abnormalities (Fig. 1; Tsukioka et al. 1997a; Caliot et al.
2012; van Sorge et al. 2014; van der Beek et al. 2015).
RhaCWP are localized on the outermost surface of the cell
wall but are likely also intercalated within the mesh-like struc-
ture of the peptidoglycan layer since antibodies directed against
these structures bind to both sides of isolated cell walls (Swan-
son and Gotschlich 1973;Wagner andWagner 1978;Wagner et al.
1980). Group-speciic antigens can also be isolated at high yield
in the growth medium (Carey et al. 1980; De Cueninck, Shock-
man and Swenson 1982; Doran and Mattingly 1982), possibly
as a result of cell wall catabolism during growth. Compared to
the cell walls of S. aureus and B. subtilis, streptococcal species
appear to lack expression of polyol-based WTA and, typically,
lack orthologues of the critical WTA biosynthesis enzymes TagB,
TagD and TagF (Sutcliffe, Black and Harrington 2008) (and un-
published observations). In contrast to streptococci, homologues
of WTA biosynthesis genes are found in lactococcal genomes.
Figure 2. Visualization of the pellicle by transmission electron microscopy. Lac-
tococcus lactis and S. agalactiae transmission electron microscope images con-
trasted with heavy metal staining method. In wild-type (WT) strains the pellicle
is visible and indicated by arrows. Loss of RhaCWP expression, due to of genetic
mutation, result in loss of pellicle expression. The scale bar represents 0.1 μm.
Consequently, L. lactis strains likely express both polyol-based
WTA and RhaCWP as part of their cell wall (Chapot-Chartier
and Kulakauskas 2014). E. faecalis expresses the most extensive
surface glycome including WTA, LTA, capsular polysaccharide
and a RhaCWP called Enterococcal polysaccharide antigen (Epa)
(Hancock and Gilmore 2002; Teng et al. 2009; Thurlow, Thomas
and Hancock 2009; Theilacker et al. 2012). In contrast to RhaCWP
in streptococci and L. lactis, Epa appears to be buried in the
cell wall precluding interaction with the immune system, at
least under laboratory conditions (Hancock and Gilmore 2002).
It should however be noted that sera from patients do con-
tain Epa-speciic antibodies (Xu, Murray andWeinstock 1998; Xu
et al. 2000; Teng et al. 2002). Also, the presence of Epa is vis-
ible under transmission electron microscopy (TEM) as a sepa-
rate electron dense outer layer (Rigottier-Gois et al. 2015), sim-
ilar to the RhaCWP layer observed in L. lactis and S. agalac-
tiae (Chapot-Chartier et al. 2010; Caliot et al. 2012) (Fig. 2). In
early studies, this electron dense outer layer was known as
the outer lamina and was initially described as microcapsule
(Baker and Kasper 1976). Recently, the term pellicle was coined
(Chapot-Chartier et al. 2010) and is preferred since the term
does not inherently imply that this layer is either ‘outer’ or
of a speciic composition (such as capsule). Interestingly, the
pellicle is not as impenetrable as TEM images suggest. In S.
agalactiae, topographic imaging and atomic force microscopy-
based single-molecule mapping on live bacteria revealed that
peptidoglycan strands can still be probed in the presence of the
GBC (Beaussart et al. 2014). However, the pellicle does shield
peptidoglycan to some extent, since loss of GBC expression
through genetic manipulation renders S. agalactiae extremely
sensitive to the activity of peptidoglycan-cleaving mutanolysin
(Caliot et al. 2012). Similarly, atomic force microscopy stud-
ies on pellicle-deicient L. lactis uncovers peptidoglycan peri-
odic bands orientated parallel to the short axis of the cell
(Andre et al. 2010).
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Chemical structure of RhaCWP
Studies focusing on the chemical composition of Lanceield
Group antigens have demonstrated that rhamnose is the major
constituent, along with variable combinations and linkages of
Glc, GlcNAc, Gal, GalNAc and phosphate (Pritchard et al. 1981).
Elucidation of Group-speciic RhaCWP structures in individual
streptococcal species provided structural evidence for the dis-
criminating capacity of the Lanceield typing scheme (Fig. 3A).
The serological distinction between Group A and Group C Strep-
tococcus is explained by expression of a terminal β-linked Glc-
NAc side chain in the Group A Carbohydrate (GAC) versus a
(GalNAc)2 side chain in the Group C Carbohydrate (GCC), respec-
tively (McCarty 1956; Krause and McCarty 1962a; Coligan, Kindt
and Krause 1978) (Fig. 3A). However, biochemical and immuno-
logical characterization of CWP isolated from so-called Group A-
and Group C-variant strains also noted that the GAC and GCC
are structurally related. These variant strains lost Lanceield
serum reactivity and displayed a variant Group antigen com-
prised of unsubstituted rhamnan with only trace amount of the
N-acetylated sugars (McCarty 1956; Krause and McCarty 1962b).
Occurrence of such variant strains appears to be a rare event;
one Group C-variant strain was isolated as a resistant clone af-
ter exposure to virulent Group C bacteriophages (Krause 1963),
whereas Group A-variant strains appear after multiple passages
through an unnatural host, such as mice, but have never been
isolated from humans (McCarty and Lanceield 1955). Whether
strains are able to vary expression, composition or length of
RhaCWP during natural infection is currently unclear. Possibly
such variants may be missed in routine diagnostics screening.
Alternatively, loss of speciic RhaCWP epitopes or loss of the
complete structurewould severely hamper the ability of the bac-
terium to colonize or infect the host, allowing rapid eradication
by the host immune system as will be described in more detail
below.
For the Group B (GBC) and G carbohydrate (GGC), rhamnose
is the major antigenic determinant (Curtis and Krause 1964a,b).
Species carrying these structures are serologically discriminated
based on the presence of either a single rhamnose in GGC
versus triterminal rhamnose in GBC (Curtis and Krause 1964a)
(Fig. 3A and B). Among the streptococcal group antigens, the
GBC is unique since it forms a multiantenna branching struc-
ture and is negatively charged, due to the presence of phospho-
diester bonds that link different GBC repeat units (Fig. 3B). Sim-
ilarly, the L. lactis RhaCWP contains phosphodiester bonds that
link hexasaccharide or pentasaccharide repeating units (Fig. 3A)
(Chapot-Chartier et al. 2010; Ainsworth et al. 2014). Unfortu-
nately, the structure of E. faecalis Epa has not yet been elucidated
but is composed of the monosaccharides glucose, rhamnose,
GlcNAc, GalNAc, galactose and probably phosphate (Hancock
and Gilmore 2002; Teng et al. 2009). The presence of phosphates
in RhaCWP of S. agalactiae, L. lactis and possibly E. faecalis likely
suggests that the functions of these structures more closely re-
semble functions exerted by WTA in other Gram-positive bacte-
ria (Michon et al. 1987, 1988, 1991; Sutcliffe 2008).
General aspects of RhaCWP genetics and biosynthesis
CWP can be structurally highly complex due the number and
variation in their monosaccharide components, diverse linkage
types and chemical substitutions such as (de)acetylation and
hydroxylation. Their biosynthesis requires the coordinated ac-
tion of glycosyltransferases (enzymes that link monosaccha-
rides), transporters and metabolic enzymes for the production
Figure 3. Schematic representation of known RhaCWP structures. (A) Schematic
representation of RhaCWP core structures in different streptococcal species and
L. lactis. GAC structure (McCarty and Lanceield 1955; Coligan, Kindt and Krause
1978; Pritchard et al. 1982; Huang, Rama Krishna and Pritchard 1986); GBC struc-
ture (Pritchard, Gray and Dillon 1984; Michon et al. 1987; 1988); GCC structure
(Krause and McCarty 1962a; Coligan, Kindt and Krause 1978); GGC structure
(Pritchard et al. 1988); S. mutans serotypes c, e, f, k (Pritchard and Furner 1985;
Pritchard et al. 1986, 1987; Nakano and Ooshima 2009); L lactis (Chapot-Chartier
et al. 2010; Ainsworth et al. 2014; Chapot-Chartier and Kulakauskas 2014). ∗For
S. mutans the glucose side chain can either be absent (serotype k) or be linked
to the rhamnan backbone in α-1,2 coniguration (serotype c), β-1,2 conigura-
tion (serotype e), or α-1,3 coniguration (serotype f). It must be noted that the
(distribution of) length(s) of the RhaCWP have not been experimentally deter-
mined. RhaCWP are likely covalently attached to peptidoglycan MurNAc. (B) Full
structure of GBC as described by (Pritchard, Gray and Dillon 1984; Michon et al.
1987, 1988) with newly recognized structural elements highlighted in boxes. Be-
cause both the repeating unit and the rhamnan stem have a basal GlcNAc moi-
ety, we hypothesize that the synthesis of each building block is initiated sep-
arately on the undecaprenyl lipid carrier by GbcO. It is recognized that either
incomplete substitution (at branch points located on the penultimate rhamnose
of the repeating unit) or further extension could create a more heterogeneous
inal structure than presented here. Phosphate groups are involved in phospho-
diester bonds linking oligosaccharides into polysaccharides.
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of nucleotide-sugar precursors. Often, genes encoding proteins
required for glycoconjugate biosynthesis are clustered on the
chromosome. Their identiication allows subsequent structure–
function studies that help to understand the role of glycosyla-
tion in bacterial (infection) biology.
It is surprising that despite the historical and medical im-
portance of the Lanceield Group antigens, no studies were un-
dertaken to decipher the genetic basis of their biosynthesis. By
contrast, capsule synthesis was quickly recognized as a major
virulence factor inmany bacterial species and has consequently
been the subject of many genetic, biochemical and functional
studies (Llull, Lopez and Garcia 2001; Cress et al. 2014). Initial
predictions for the genetic basis of Lanceield Group carbohy-
drate biosynthesis were postulated upon availability of the irst
streptococcal genome sequences (Ferretti et al. 2001; Glaser et al.
2002; Holden et al. 2009; Shimomura et al. 2011). For S. agalactiae,
the availability of the GBC structure and genome sequence en-
abled a comprehensive and detailed in silico analysis that linked
protein-encoding genes to the different glycosidic linkages in
the GBC structure (Sutcliffe, Black and Harrington 2008). That
study demonstrated that most, but not all, of the enzymatic ac-
tivities for synthesis and transport of the mature GBC molecule
are present in the predicted 15 kB GBC gene cluster (Sutcliffe,
Black and Harrington 2008); proteins required for lipid carrier
activation and peptidoglycan anchoring of GBC seemed to be
encoded elsewhere on the genome (Sutcliffe, Black and Harring-
ton 2008). As will be discussed below, this split in gene organiza-
tion, correlating with different biosynthetic steps, appears to be
a common feature of the streptococcal and lactoccocal RhaCWP
biosynthesis pathway. In addition, the biosynthesis of RhaCWP
requires the production of appropriate nucleotide sugars pre-
cursors. We will only cover dTDP-L-rhamnose biosynthesis here
given its characteristic presence in RhaCWP, as well as the pos-
sible therapeutic implications of this pathway. We will then dis-
cuss the genetic organization and putative biosynthesis path-
way of RhaCWP.
L-rhamnose biosynthesis
Incorporation of L-rhamnose into polysaccharide structures
in both Gram-positive and Gram-negative bacteria requires
the formation of the nucleotide sugar precursor dTDP-L-
rhamnose. dTDP-L-rhamnose is produced from glucose-1-
phophate through a conserved four-step enzymatic reaction
that has been characterized both biochemically and structurally
(Fig. 4) (Giraud and Naismith 2000; Dong et al. 2003a). In the irst
step of the pathway, RmlA, a glucose-1-phosphate thymidyl-
transferase, converts glucose-1-phosphate into dTDP-glucose
(Blankenfeldt et al. 2000), which is subsequently oxidized and
dehydrated to form dTDP-4-keto-6-deoxy-D-glucose by the
dTDP-D-glucose 4,6-dehydratase RmlB (Beis et al. 2003). RmlC
catalyzes an unusual double epimerization reaction (Giraud
et al. 2000; Dong et al. 2003b; 2007), the product of which is i-
nally reduced by RmlD, a dTDP-4-dehydrorhamnosereductase,
to form dTDP-L-rhamnose (Blankenfeldt et al. 2002; van der Beek
et al. 2015). Initial structure elucidation of the Rml enzymes
from different species, including Pseudomonas aeruginosa (RmlA),
Salmonella enterica (RmlC and RmlD) and Streptococcus suis (RmlB
and RmlC), demonstrated that rhamnose biosynthesis enzymes
require dimerization or even dimerization of dimers to catalyze
the respective enzymatic reactions (Blankenfeldt et al. 2000;
Giraud et al. 2000; Blankenfeldt et al. 2002; Beis et al. 2003; Dong
et al. 2007). However, recent structural and biochemical charac-
terization of the S. pyogenes RmlD homologue provided surpris-
Figure 4. L-rhamnose biosynthesis pathway. Four-step catalytic reaction result-
ing in dTDP-L-rhamnose production from D-glucose-1-phosphate.
ing insight that, in this species, RmlD is active as a monomer
(van der Beek et al. 2015). Subsequent comprehensive bioin-
formatics analysis of 213 putative RmlD sequences indicates
that the monomeric form of RmlD is more widespread through-
out the bacterial kingdom compared to the originally described
RmlD from Salmonella (Blankenfeldt et al. 2002; van der Beek et al.
2015). The beneit of either structure to the enzymatic reaction
is currently unknown.
In many bacteria, such as in E. faecalis (Xu, Murray and We-
instock 1998), Shigella lexneri (Macpherson, Manning and Mo-
rona 1994), L. lactis (Dupont et al. 2004), S. pneumoniae (Bentley
et al. 2006) and S. enterica (Jiang et al. 1991), the RmlA-D proteins
are encoded by a single genetic locus, rmlABCD. The rml genes
are likely transcribed as an operon, although experimental evi-
dence for that is currently lacking. In contrast, in some bacteria
the rml genes display a split architecture, often clustering rm-
lABC, but excluding rmlD. This is for example the case in My-
cobacterium tuberculosis (Ma et al. 2001) and several streptococcal
species (Tsukioka et al. 1997a,b; van der Beek et al. 2015). The evo-
lutionary origin or functional beneit of a split versus clustered
gene architecture is remains to be determined.
The contribution of Rml enzymes to L-rhamnose biosyn-
thesis has been demonstrated in several species through a
genetics approach, i.e. mutation of any of the rml genes re-
sults in loss of L-rhamnose in the bacterial cell walls (Tsukioka
et al. 1997a,b; Rahim et al. 2000; Carvalho et al. 2015; van der
Beek et al. 2015). For other species, loss of L-rhamnose in the
cell wall was not conirmed by cell wall composition analy-
sis upon mutation of rml genes (Chiang and Mekalanos 1999;
Xu et al. 2000). Importantly, disruption of dTDP-L-rhamnose
biosynthesis severely attenuates bacterial itness and/or viru-
lence (Tsukioka et al. 1997a; Chiang and Mekalanos 1999; Rahim
et al. 2000; Xu et al. 2000; Carvalho et al. 2015; van der Beek et al.
2015). The position or percentage of incorporated L-rhamnose
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likely dictates whether rml genes are essential. For example, in
M. tuberculosis, L-rhamnose covalently links arabinogalactan to
peptidoglycan, which is critical for the overall architecture of the
Mycobacterial cell wall,making L-rhamnose biosynthesis essen-
tial (McNeil, Daffe and Brennan 1990; Ma, Pan and McNeil 2002).
Similarly in S. pyogenes, L-rhamnose is incorporated in the GAC
that comprises half of the cell wall mass (McCarty 1952), ren-
dering depletion lethal (Le Breton et al. 2015; van der Beek et al.
2015). In the case of uropathogenic Escherichia coli and P. aerugi-
nosa,mutation of rmlD results in loss of O-antigen expression but
leaves the lipopolysaccharide core and lipid A structure intact,
yielding viable bacteria (Burns and Hull 1998; Rahim et al. 2000).
However, loss of rhamnose does come at a certain cost, since
rhamnose-deicient E. coli are extremely sensitized to serum-
mediated killing (Burns and Hull 1998).
Analysis of its genomic location in members of the family
Streptococcaceae and in E. faecalis reveal that rmlD is system-
atically associated with a large cluster of genes encoding
glycosyltransferases, polysaccharide transport systems, sugar
biosynthesis enzymes and genes of unknown functions (Fig. 5).
Experimental evidence in selected streptococcal species, L. lac-
tis and E. faecalis conirms that rmlD-associated loci participate
in the biosynthesis of RhaCWP as will be discussed in the next
section.
Biosynthesis of RhaCWP
Biosynthesis of glycosylated surface structures in bacteria dis-
plays some common themes, despite the considerable diver-
sity in the chemical composition of glycosylated structures
(reviewed in Tytgat and Lebeer 2014). In general, glycoconju-
gate biosynthesis proceeds as follows (Fig. 6); (1) initiation of
biosynthesis through activation of a lipid carrier, often unde-
caprenylphosphate, on the cytoplasmic side of the membrane,
(2) elongation of the polysaccharide (building block) on the
lipid carrier by sequential addition of activated sugar precur-
sors, (3) translocation of lipid-linked precursors, either repeating
units or the complete glycoconjugate, across the membrane by
ABC transporters or ‘lippases’ (Lazarevic and Karamata 1995),
(4) linkage of the glycoconjugate to peptidoglycan or protein
(Kawai et al. 2011; Chan et al. 2013) and (5) additional modii-
cations to the glycoconjugate that can occur after cell wall an-
choring. In some cases, the mature glycoconjugate is formed by
polymerization of translocated repeating units between steps
(3) and (4) by a dedicated polymerase. Since undecaprenylphos-
phate serves as a common scaffold to build structurally diverse
glycoconjugates including capsules, peptidoglycan, lipopolysac-
charides and protein-modifying glycans, the availability of ‘free’
undecaprenylphosphate is essential for bacterial survival (Hart-
ley and Imperiali 2012).
In accordance with the general steps of glycoconjugate
biosynthesis (Fig. 6), biosynthesis of RhaCWP is likely ini-
tiated on the inside of the cytoplasmic membrane on an
undecaprenylphosphate lipid carrier, before the structure is
transported across the membrane and attached to peptidogly-
can. Indeed, most enzymes involved in RhaCWP biosynthesis
are predicted to be intracellular or incorporated in the mem-
brane. Furthermore, lysed protoplasts of S. pyogenes incorpo-
rate 14C-labeled dTDP-rhamnose into a polysaccharide struc-
ture, presumably the GAC (Zeleznick et al. 1963). The proteins
required for elongation and translocation of RhaCWP appear to
be encoded by rmlD-associated gene clusters (Fig. 5).Within each
cluster, we ind genes encoding glycosyltransferases, putative
transport systems (either an ABC transport system or putative
lippase), sugar modifying enzymes for the production of spe-
ciic sugar precursors, and hypothetical proteins which can be
unique for the species (Sutcliffe, Black and Harrington 2008). En-
zymes for initiation (Fig. 6; step 1) and peptidoglycan anchor-
ing after transport (Fig. 6; step 4) are encoded elsewhere on the
genome in most species. It is beyond the scope of this review
to discuss the putative role of each gene in detail; instead, we
aim to provide genetic and biochemical insights concerning the
proposed steps of the RhaCWP biosynthesis pathway.
Lipid carrier activation by UDP-GlcNAc:lipid phosphate transferases
The available structures of RhaCWP as well as evidence for their
covalent linkage to peptidoglycanMurNAc (Heymann,Manniello
and Barkulis 1967; Deng et al. 2000) implies that activation of
the lipid carrier undecaprenylphosphate by the transfer of Glc-
NAc by a UDP-GlcNAc:lipid phosphate transferase is the irst
enzymatic step of RhaCWP biosynthesis. This step is similar to
the initiating reaction for WTA biosynthesis in B. subtilis and S.
aureus,which is catalyzed by integral membrane proteins called
TarO/TagO (Swoboda et al. 2010). A gene encoding a TarO/TagO
homologue is not present in the rmlD-associated gene clusters
in streptococci and L. lactis (Fig. 5), but can be readily identiied
elsewhere in the genome through homology searches. Atypi-
cally in E. faecalis, the irst gene of the putative RhaCWP gene
cluster, epaA, may encode the required UDP-GlcNAc:lipid phos-
phate transferase (Fig. 5). Experimental proof for a role of these
enzymes in the biosynthesis of RhaCWP has been provided for
S. pyogenes GacO, S. agalactiae GbcO, S. mutans RgpG and E. fae-
calis EpaA through geneticmutation, bacterial complementation
studies or pharmacological inhibition of the transferase by the
compound tunicamycin (Yamashita et al. 1999; Teng et al. 2009;
Campbell et al. 2011; Caliot et al. 2012; van Sorge et al. 2014).
Indeed, interference with expression or enzymatic function of
these transferases depleted the cell wall of L-rhamnose, atten-
uated bacterial growth and induced aberrant morphology and
cell division resulting in an increased chain length (Yamashita
et al. 1999; Teng et al. 2009; Caliot et al. 2012; van Sorge et al. 2014).
Correspondingly, the S. agalactiae gbcOmutant lost expression of
the pellicle (Fig. 2) (Caliot et al. 2012), conirming previous ob-
servations in L. lactis that this outer layer correlates with the
presence of RhaCWP (Fig. 2) (Chapot-Chartier et al. 2010). For
streptococci, this phenotype mimics the defects observed in rml
mutants, which also lose expression of RhaCWP and display
attenuated growth, aberrant morphology and growth in long
chains (Fig. 1) (Tsukioka et al. 1997a; van der Beek et al. 2015).
Glycosyltransferases required for RhaCWP biosynthesis
Following lipid carrier activation by UDP-GlcNAc:lipid phos-
phate transferases, biosynthesis of the actual RhaCWP struc-
ture occurs through the step-wise addition of monosaccharides
by speciic glycosyltransferases. In most cases, each glycosidic
bond requires a dedicated enzyme. Such knowledge informs de-
tailed structure–function studies of RhaCWP aswill be discussed
below.
The Lanceield GAC, GCC and S. mutans RhaCWP con-
tain a backbone composed of α-1,2-/α-1,3-linked polyrhamnose
(Fig. 3A). The irst seven genes of the respective RhaCWP gene
clusters contain a high sequence identity, suggesting that these
genes are required to construct the identical rhamnan back-
bone (Fig. 5). Indeed, heterologous expression of these seven
genes of S. mutans in E. coli results in the production of α-1,2-
/α-1,3-linked polyrhamnose (Shibata et al. 2002). Subsequently,
Shibata et al. identiied that three glycosyltransferases encoded
in this partial cluster, RgpA, RgpB and RgpF, are required for
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Figure 5. Comparison of the RhaCWP biosynthesis gene clusters in streptococcal species, L. lactis and E. faecalis. The RhaCWP biosynthesis genes are often located in
rmlD-associated gene clusters. The loci vary between 14 and 26 kB in size encoding between 12 and 25 genes with annotated functions such as glycosyltransferases,
polysaccharide biosynthesis proteins, rhamnose biosynthesis proteins (Rml proteins) and putative transport molecules. Each function is indicated by a different color.
A representative gene cluster of a single species is presented and abbreviated gene annotations are indicated below. Arrows are drawn to scale with gene size. The
RhaCWP gene clusters of the following strains are shown: S. pyogenes strain M5005 spy0602 – spy0613; S. agalactiae NEM316 gbs1480 – gbs1494; S. equi subs equisimilis
MGCS10565 Sez837 – Sez850; S. dysgalactiae sub equisimilis GGS˙124 SDEG750 – SDEG764; S. mutans UA159 SMU.824 – SMU.836; E. faecalis V583 EF2198 – EF2174; L. lactis
MG1363 llmg0206 – llmg0228. TM, transmembrane
rhamnan biosynthesis, with RgpA adding the irst rhamnose to
the undecaprenylphosphate-GlcNAc lipid carrier (Shibata et al.
2002). Homologous glycosyltransferases in S. pyogenes and S.
zooepidemicus likely catalyze a similar reaction. Decoration of the
rhamnan backbone with speciic side chains produces the dis-
criminating epitopes of the GAC, GCC and RhaCWP of S. mu-
tans (Fig. 3A). The remaining glycosyltransferases in the respec-
tive gene clusters are likely implicated in these reactions. For
S. mutans, RgpE and RgpI add α1,2-linked glucose to RhaCWP
(Yamashita et al. 1998; Ozaki et al. 2002), whereas GacI in S. pyo-
genes likely adds the characteristic β-linked GlcNAc side chain
since mutation of gacI results in loss of side chain expression
(van Sorge et al. 2014). For construction of the GCC side chain, a
disaccharide GalNAc (Fig. 3A), glycosyltransferases encoded by
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Figure 6. General steps in glycoconjugate biosynthesis. Despite glycoconjugate diversity, bacterial glycoconjugate biosynthesis is quite conserved and proceeds in ive
basic steps: (1) initiation of biosynthesis through activation of a lipid carrier on the cytoplasmic side of themembrane, (2) elongation by sequential addition of activated
monosaccharides by glycosyltransferases to form the polysaccharide on the polyprenoid linker, (3) translocation of lipid-linked precursors across the membrane by
ABC transporters or ‘lippases’, (4) linkage of the glycoconjugate to peptidoglycan by LytR/CpsA/Psr proteins, and (5) additional modiications to the glycoconjugate
that can occur after anchoring to the cell wall, for example alanylation of wall teichoic acid. GlcNAc, N-acetylglucosamine. UDP-GlcNAcP transferase, UDP-GlcNAc:lipid
phosphate transferase
Sez 0844 and Sez 0848 likely play a crucial role. Similar to the
GAC, GCC and RhaCWP of S. mutans, the Lanceield GGC is also
reported to be a linear structure (Pritchard et al. 1988), albeit
with a different disaccharide backbone (Fig. 3A). No studies have
experimentally addressed the contribution of speciic glycosyl-
transferases to the biosynthesis of the GGC, but the increased
number of glycosidic bonds compared to the GAC, GCC and S.
mutans RhaCWP, suggest that the activity of all seven glycosyl-
transferases encoded in the gene cluster (Fig. 5) are required for
its biosynthesis.
The situation is more complex in the case of the pellicle-
forming GBC and RhaCWP of L. lactis strains. The GBC was pre-
viously postulated to be composed of four modular subunits
(Sutcliffe 2008), which are ultimately linked together via phos-
phodiester bonds to form a multiantenna branching structure
(Fig. 3B). Despite its structural complexity, it was hypothesized
that a minimum of 11 glycosyltransferases would theoretically
be required to compose all glycosidic linkages in the GBC, seven
of which are encoded within the GBC gene cluster (Sutcliffe,
Black and Harrington 2008). However, upon reexamination of
the GBC structure (Michon et al. 1987, 1988, 1991), we have
recognized the presence of two key structural elements, both
beginning with GlcNAc: a stem oligosaccharide and a repeat-
ing unit (Fig. 3A, B). Following transfer of GlcNAc to the unde-
caprenylphosphate lipid carrier by the GbcO UDP-GlcNAc:lipid
phosphate transferase, cytoplasmic synthesis of both of these
subunits could be achieved by the glycosyltransferases encoded
in the GBC gene cluster (unpublished observations). Identiica-
tion of this repeat unit allows for a revised model of GBC as-
sembly (see below) and solves the mystery of the two ‘missing’
GlcNAc transferases (Sutcliffe, Black and Harrington 2008).
In contrast to the invariable structure of the GAC, GBC, GCC
and GGC in the respective streptococci, L. lactis strains can
express structurally diverse CWP structures, correlating to di-
versity in the responsible gene cluster (Chapot-Chartier et al.
2010; Mahony et al. 2013; Ainsworth et al. 2014; Farenc et al.
2014). Rhamnose is not incorporated into the CWPof every strain
(Ainsworth et al. 2014). Bioinformatics predict the presence of
eight glycosyltransferases in the L. lactis pellicle gene cluster
but for none of them a contribution or role has been experi-
mentally addressed. Currently, the structure of the E. faecalis Epa
awaits elucidation,making it dificult to speculate about the spe-
ciic glycosyltransferases involved. However, genetic disruption
of epaB and epaN, which encode putative glycosyltransferases
(Fig. 5), changes immunoreactivity of Epa, indicating that these
enzymes are involved in Epa biosynthesis (Xu,Murray andWein-
stock 1998; Teng et al. 2002, 2009). Moreover, the Epa polysaccha-
ride extracted from the epaB mutant was incapable of incor-
porating rhamnose and instead included mannose, suggesting
that epaB encodes a rhamnosyltransferase (Teng et al. 2009).
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RhaCWP translocation and incorporation into the cell wall
Transport of big sugar complexes across cell membranes is en-
ergetically unfavorable and requires one of three mechanisms,
i.e. synthase-dependent transporters, ABC transporters, or so-
called ‘lippases’ (Cuthbertson, Kos and Whitield 2010). The
synthase-dependent pathway is least well deined and is in-
volved in the formation of polysaccharides such as chitin, cellu-
lose, hyaluronan and poly-N-GlcNAc. It was recently conirmed
that a single protein, the synthase, executes both polymer-
ization and export of the growing polysaccharide chain (Mor-
gan, Strumillo and Zimmer 2013). ABC transporters translocate
longer glycan chains and can be composed of a single pro-
tein (for example PglK; Perez et al. 2015) or of a two-protein
complex consisting of a permease protein and an ATP-binding
protein (Cuthbertson, Kos and Whitield 2010). Finally, classical
Wzx lippase systems generally transport oligosaccharide repeat
units that are polymerized on the extracytoplasmic face of the
membrane by a Wzy-like polymerase to complete the mature
polysaccharide (Islam and Lam 2013). Interestingly, genes con-
sistent with either the Wzx lippase and/or the ABC transport
system seem to be present in all RhaCWP gene clusters (Fig. 5).
Currently, the only experimental evidence supporting a role for
the cognate ABC transport system is for S. mutans (Shibata et al.
2002). After heterologous expression of the irst seven (rmlD-
rgpABCDEF) genes in E. coli and subsequent disruption of the ABC
transporter-encoding genes (rgpCD), the bacteria were unable
to produce rhamnan (Shibata et al. 2002). This transport mech-
anism would resemble WTA translocation, which involves the
TagG/H ABC transport system (Lazarevic and Karamata 1995).
The translocation of the GBC structure remains particularly
enigmatic, given that assembly of a fully branched polymer be-
fore translocation would present a major challenge (Sutcliffe,
Black and Harrington 2008). In contrast to the other RhaCWP
gene clusters, the GBC gene cluster only contains a putative
Wzx lippase gene (gbs1482) as well as two integral membrane
proteins (encoded by gbs1483 and gbs1490) that may act as ac-
cessory proteins (Sutcliffe, Black and Harrington 2008). Recogni-
tion that the GBC is composed of two structural elements (stem
oligosaccharide and a repeat unit, Fig. 3B) instead of the previ-
ously predicted four elements, now allows for a revised route of
synthesis. Flipping of these two building blocks (by GBS1482 and,
presumptively, a second lippase) could allow assembly of the
mature GBC on the extracytoplasmic face of themembrane. The
integral membrane proteins (GBS1484, GBS1489 or GBS1490) can
be proposed as the second lippase and/or assembly proteins.
Assembly of repeating units requires formation of linkages be-
tween the GlcNAc and C3 of a terminal rhamnose in the grow-
ing chain, whilst the branch points are formed by repeating unit
linkage to the C4 of the penultimate rhamnose. An attractive as-
pect of this revised proposed biosynthesis is that it removes the
need for as yet unidentiied cytoplasmic GlcNAc transferases.
In addition, it would allow lipping of smaller units instead of
the fully branched GBC, which is likely energetically more favor-
able. Thus, complete synthesis, translocation and assembly of
the GBC can be predicted to occur through the action of GbcO
and the proteins encoded in GBC gene cluster. Experimental ev-
idence to support these hypotheses should now be sought.
Detailed biochemical analysis has demonstrated that the
GAC and GBC are attached to the MurNAc moiety of peptidogly-
can, similar to WTA in other Gram-positive bacteria (Swoboda
et al. 2010). GAC is presumably connected to MurNAc through a
phosphate containing bridge composed of one or more units of
glycerol (Heymann, Manniello and Barkulis 1967), which would
concur with the linkage of WTA to peptidoglycan in S. aureus
(Swoboda et al. 2010). The transfer of nascent RhaCWP from the
lipped lipid carrier onto the peptidoglycan is likely catalyzed by
a member of the LytR-CpsA-Psr family. These proteins were ini-
tially identiied to catalyze the attachment of WTA to peptido-
glycan in B. subtilis (Kawai et al. 2011). This family of proteins
is widespread throughout Gram-positive bacteria, with at least
two family members present in the genomes of streptococci up
to ive in E. faecalis (Hubscher et al. 2008). The LytR-CpsA-Psr pro-
teins appear to be highly redundant since lack of peptidoglycan-
attached glycopolymers, such as capsule and WTA, only be-
comes apparent upon genetic mutation of all encoded enzymes
(Kawai et al. 2011; Eberhardt et al. 2012; Chan et al. 2013, 2014).
The LytR-CpsA-Psr phosphotransferases typically hydrolyze the
phosphodiester linkage between the lipid-carrier and the irst
GlcNAc at the stem base of the polysaccharide (i.e. they hy-
drolyze the linkage created by the UDP-GlcNAc:lipid phosphate
transferase such as GacO and GbcO) and attach the polymers to
peptidoglycan via a phosphate ester linkage (Kawai et al. 2011;
Eberhardt et al. 2012; Chan et al. 2013). Overall, it seems likely
that LytR-CpsA-Psr proteins are involved in anchoring RhaCWP
to the cell wall, but experimental proof is currently lacking.
Distribution of RhaCWP throughout bacteria: identiication of addi-
tional RhaCWP gene clusters
As mentioned above, the Lanceield typing scheme is unable
to discriminate bacteria up to the species level. The avail-
ability of genome sequences, as well as knowledge regarding
RhaCWP gene clusters, provides an opportunity to gain in-
sight into the distribution and potential structure of RhaCWP
among Gram-positive bacteria. For example, S. castoreus was
noted to react with Group A-speciic antisera and indeed its
draft genome contains a biosynthetic locus syntenous with that
of the GAC of S. pyogenes (Table S1, Supporting Information).
However, the presence of an additional glycosyltransferase com-
pared to the GAC gene cluster in S. pyogenes suggests some
ine structural variation. Likewise, the GBC has been reported
to be expressed by different streptococcal species most notably
Streptococcus porcinus, Streptococcus pseudoporcinus, Streptococcus
troglodytidis and Streptococcus plurextorum. Correspondingly, the
genomes of S. pseudoporcinus and S. porcinus contain a fully
syntenous GBC biosynthetic gene cluster except for the lack
of a gbs1485 orthologue (unpublished observations). Presum-
ably, the expressed structures only lack one of the monosaccha-
ride rhamnose side-branches present in the GBC repeating unit
(Fig. 3B) (Sutcliffe, Black and Harrington 2008), but can still
make the linear trirhamnosyl immunodominant epitope with a
terminal rhamnose that is detected by Group B-speciic serotyp-
ing (Curtis and Krause 1964b). In contrast, Streptococcus tho-
raltensis contains a GBC-variant gene cluster that lacks or-
thologues of two of the predicted rhamnosyltransferases,
gbs1481 and gbs1485, present in S. agalactiae (Table S2, Sup-
porting Information) and this species is non-groupable by
Lanceield serotyping assays. Instead of gbs1481 and gbs1485,
the S. thoraltensis locus harbors two additional glycosyltrans-
ferases absent in the otherwise syntenous locus of S. agalactiae
(Table S2, Supporting Information). Absence of a gbs1481 or-
thologue is likely responsible for abrogated cross-reactivity
in the Group B antigen serotyping tests due to the loss of
the terminal rhamnose from the dominant trirhamnosyl epi-
tope. This analysis therefore suggests that S. thoraltensis is ca-
pable of synthesizing a RhaCWP that is a structural variant
of the GBC. Increased availability of genome sequences for
streptococci and related species will help identify additional
rmlD-linked gene clusters for RhaCWP biosynthesis that are
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consistentwith either known Lanceield serotyping reactions (as
exempliied here by S. castoreus) or from which variant or novel
RhaCWP structures can be predicted.
Physiological role of RhaCWP
Since their identiication and structural characterization from
the 1930s onwards, the biological roles of the Lanceield Group
antigens or other RhaCWP have received little attention. It
was long thought that Group-speciic antigens were only of
structural importance (McCarty 1952). Indeed, complete loss of
RhaCWP expression through genetic mutation results in severe
growth and cell division abnormalities (Fig. 1) and can be es-
sential under competing conditions (McCarty 1952; Tsukioka
et al. 1997a; Caliot et al. 2012; van der Beek et al. 2015). Caliot
et al. (2012) targeted theUDP-GlcNAc:lipid phosphate transferase
gbcO (gbs0136) of S. agalactiae to initiate functional studies on
the GBC. The resulting GBC-negative S. agalactiae strain was de-
void of cell wall rhamnose and phosphate and lost expression of
the pellicle structure (Caliot et al. 2012) (Fig. 2). The loss of GBC
was associated with major morphological and cell growth de-
fects, includingmislocated septa and defects in cell division and
separation, which resulted in the formation of very long chains
(Caliot et al. 2012). This phenotype corresponds to previous de-
scriptions of a stable opacity variant of S. agalactiae that had lost
GBC expression and displayed growth and morphological de-
fects (Pincus et al. 1992, 1993). For this spontaneous opaque S.
agalactiaemutant strain the underlying genetic defect has never
been clariied. For the gbcOmutant strain, the defects result from
reduced levels of highly cross-linked peptidoglycan and mislo-
calization of the important peptidoglycan hydrolase PcsB (Caliot
et al. 2012), a protein required for streptococci cell wall separa-
tion (Reinscheid et al. 2003; Sham et al. 2011). The latter observa-
tion is reminiscent of studies in S. aureus, where the preferen-
tial localization of the major autolysin Atl is lost in absence of
WTA (Schlag et al. 2010). Collectively, these observations support
a role of GBC in cell wall homeostasis of S. agalactiae. In line with
observations in the S. agalactiae gbcO mutant (Caliot et al. 2012),
pharmacological inhibition of the S. pyogenes enzyme GacO (en-
coded by M5005 Spy0240) by tunicamycin resulted in depletion
of GAC from the cell wall, increased mutanolysin susceptibility
and increased chain length as a result of cell separation defects
(van Sorge et al. 2014). However, interpretations from these stud-
ies may be obscured by the interconnection between biosyn-
thesis of Group-speciic antigens and that of other cell wall
glycopolymers, including peptidoglycan, sincemost glycoconju-
gates use undecaprenylphosphate as a carrier for biosynthesis.
Coordinated regulation between biosynthesis of different glyco-
conjugates is further supported by the observation that the S.
agalactiae gbcOmutant increases capsule production suggesting
a coordinated regulation between the two glycoconjugates
(Beaussart et al. 2014). Knowledge regarding the interrelated-
ness of glycoconjugate biosynthesis pathways is relevant for the
design of new antibiotics since interference of such connected
pathwaysmay have synergistic effects as recently demonstrated
for WTA and peptidoglycan biosynthesis (Sewell and Brown
2014).
RhaCWP as phage receptors
In addition to their signiicant role in cell wall architecture, it
is appreciated that RhaCWP are important phage receptors for
many species. This again highlights a parallel withWTA in other
Gram-positive bacteria whereWTA is critical to phage-mediated
horizontal gene transfer (Baptista, Santos and Sao-Jose 2008;
Brown et al. 2012; Winstel et al. 2014). For several streptococci,
the speciicity of phage adsorption correlates to the side chain
anchored to the rhamnan backbone. Indeed, the (GalNAc)2 side
chain of the GCC serves as an attachment site for Group C1
bacteriophage in Group C Streptococcus (Krause 1957; Fischetti
and Zabriskie 1968). Correspondingly, a Group C-variant strain,
which completely lacks the immunodominant (GalNAc)2 epi-
tope, was isolated fromGroup C Streptococcus that survived expo-
sure to Group C1 lytic phages (Krause 1963). Also for S. pyogenes,
the GAC-speciic GlcNAc terminal moiety appears to be involved
in both lytic and temperate phage adsorption although addi-
tional unidentiied cell wall factors are also involved (Fischetti
and Zabriskie 1968). Finally, speciic phages recognize the α-1,2-
linked glucose side chain of serotype c S. mutans strains (Shi-
bata, Yamashita and van der Ploeg 2009). For L. lactis, selection
of phage resistant strains from a random insertional mutagene-
sis library originally identiied the presence and genetic locus of
the RhaCWP (Dupont et al. 2004). Moreover, the precise structure
of the RhaCWP dictates bacteriophage sensitivity (Dupont et al.
2004; Mahony et al. 2013; Ainsworth et al. 2014). Finally, structural
changes in E. faecalis Epa through genetic manipulation greatly
affect phage sensitivity despite similar adsorption levels (Teng
et al. 2009). Phage dynamics within the bacterial population will
impact itness and may also be important for horizontal gene
transfer, even across long phylogenetic distances (Winstel et al.
2013), affecting virulence or antibiotic resistance of pathogens.
Thus the interactions of phages with RhaCWP are likely to im-
pact on bacterial population structure. In the case of L. lactis,
knowledge regarding the molecular mechanisms of phage ad-
sorption and infection may beneit the food industry.
Role of RhaCWP in virulence
The localization of RhaCWP at the host–pathogen interface sug-
gests that their biological function might be broader than a
role in cell wall biogenesis. Similarly for WTA, evidence is ac-
cumulating for its role in virulence by increasing adherence and
immune evasion (Carvalho et al. 2015; Winstel et al. 2015). Re-
cent studies in S. pyogenes and E. faecalis now highlight that
subtle modiications to the RhaCWP structure, which do not
impact bacteria growth, can signiicantly impact virulence (Xu
et al. 2000; Teng et al. 2009; van Sorge et al. 2014). For E. fae-
calis, disruption of epaB, epaE, epaM and epaN, which may com-
pletely eliminate Epa expression or only modify its structure, all
caused signiicant attenuation in a mouse peritonitis model (Xu
et al. 2000; Teng et al. 2009). Reduced virulence correlated with
increased phagocytic uptake and clearance by neutrophils (Teng
et al. 2002). Similarly in L. lactis, loss of the pellicle results in 10-
fold more eficient uptake by macrophage cell lines compared
to wild-type bacteria (Chapot-Chartier et al. 2010). These results
therefore indicate that the pellicle can exert an anti-phagocytic
effect both for L. lactis and E. faecalis. For S. pyogenes, structure–
function studies focused on the role of the GAC GlcNAc side
chain, which was selectively removed through genetic muta-
tion of the glycosyltransferase-encoding gene gacI (van Sorge
et al. 2014). The gacI mutant bacteria still expressed the rham-
nan backbone but did not display apparent cell wall abnor-
malities. However, bacteria were increasingly susceptible to
innate immune clearance by neutrophils and antimicrobial
components (van Sorge et al. 2014). Moreover, virulence of
this genetically engineered Group A-variant strain was signii-
cantly attenuated in two animal models (van Sorge et al. 2014).
Again, this indicates that speciic epitopes of RhaCWP increase
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bacterial immune resistance, although the mechanism has not
been well deined. In addition to increased immune resistance,
RhaCWP may modulate host immune responses by target-
ing speciic lectin receptors (carbohydrate-recognizing pattern-
recognition receptors) (Sancho and Reis e Sousa 2012). Hu-
man lectins regulate fundamental immunological processes but
also directly engage microbial carbohydrates, linking pathogen
recognition to appropriate immune responses. Although this of-
ten promotes bacterial clearance, lectin targeting can also pro-
mote bacterial survival by skewing immune reponses (van Vliet
et al. 2009). Research in this area should provide insight whether
the virulence-promoting effect of RhaCWP occurs through in-
teraction with lectin receptors. Alternatively, decoration of the
rhamnan backbone or rhamnose moieties by common sugars
such as GlcNAc, glucose and GalNAc may be a strategy for
microorganisms to avoid immune recognition. This is relevant
since the absence of rhamnose in humans makes rhamnose an
attractive pattern-associated molecular pattern (PAMP). Indeed,
in ish and invertebrates, rhamnose is targeted by the innate im-
mune system through germ-line encoded pattern-recognition
receptors called rhamnose-binding lectins (Ogawa et al. 2011; Ng
et al. 2014). Interestingly, rhamnose-binding lectins agglutinate
both Gram-positive and Gram-negative bacteria through inter-
action with glycan structures such as LPS or lipoteichoic acid
in the bacterial cell wall (Tateno et al. 2002; Cammarata et al.
2014; Ng et al. 2014). Rhamnose-binding lectins are also involved
in inlammatory responses through the induction of cytokines
(Watanabe et al. 2009). Humans lectins with speciicity for rham-
nose have not been identiied yet, but their existence might be
anticipated given the estimated presence of over 150 glycan-
binding proteins in humans, many with uncharacterized ligand
speciicity (Zelensky and Gready 2005; Drickamer 2014). Overall,
the role of RhaCWP in pathogenesis and cell physiology is just
starting to be appreciated. Further investigations are likely to
unravel new bacterial immune evasion strategies but may also
contribute to new insights into innate immune responses and
recognition.
Rhamnose containing capsules in Gram-positive
bacteria
Rhamnose is not just incorporated in RhaCWP, but is also
present in capsular polysaccharides. We consider this struc-
ture distinct from RhaCWP given their localization in the cell
wall; RhaCWP are interpolated within the peptidoglycan wall
layer, whereas capsular polysaccharides are typically the out-
ermost layers of the cell envelope. Nevertheless, it is worth not-
ing that several clinically relevant Gram-positive bacteria syn-
thesize rhamnose-containing capsules. The signiicance of the
S. pneumoniae capsule as a key virulence factor has been es-
tablished since the 1928 landmark ‘Grifiths experiment’ and
the capsular polysaccharides are major protective antigens uti-
lized in current vaccine formulations (Geno et al. 2015). Of the
41 (out of 46) serogroups of pneumococcal capsule for which
carbohydrate composition or structural information is available,
17 of these (∼40%) contain rhamnose, including those of clin-
ically signiicant serogroups such as 6, 19 and 23. The capsular
biosynthetic loci for these serogroups all contain rmlABCD genes
(Bentley et al. 2006). The presence of these genes in the biosyn-
thetic loci for which capsular polysaccharide structures are not
yet available or may be incomplete (e.g. serogroups 21, 40 and
48) suggests additional structures also contain rhamnose. Thus,
rhamnose biology is likely of signiicance in much of the S. pneu-
moniae population and at least nine of the serotype antigens in-
cluded in the current 23-valent vaccin are rhamnose-containing
polysaccharides (Geno et al. 2015).
In addition to S. pneumoniae, S. agalactiae strains belonging
to serotype VIII contain rhamnose within the polysaccharide
repeating unit (Kogan et al. 1996; Cieslewicz et al. 2005). This
serotype remains relatively rare globally but has been reported
to be of signiicance in some population groups, notably in Japan
and the Paciic (Lachenauer et al. 1999; Edmond et al. 2012).
Therapeutic and technological applications
Increased knowledge regarding the biosynthesis and function of
RhaCWP could aid the development of new antimicrobial agents
but may also have applications inmetabolic engineering to opti-
mize food production (Chapot-Chartier 2014) or glycoconjugate
production for medical purposes (Jaffe et al. 2014). Clearly, the
L-rhamnose biosynthesis pathway holds promise for antimicro-
bial drug targeting, given the loss of virulence and/or viability
upon rhamnose depletion in a wide range of Gram-positive and
Gram-negative bacteria. More importantly, lack of L-rhamnose
in humans should preclude off-target effects lowering risks of
unwanted side effects. Thus far, several inhibitors screens for
Rml enzymes have been initiated, resulting in only one RmlA
inhibitor targeting P. aeruginosa with some marginal activity
againstM. tuberculosis (Alphey et al. 2013). In addition to targeting
rhamnose, inhibition of other steps in the RhaCWP biosynthesis
pathway could also be of interest. Although this may not im-
mediately kill the bacterium, it may act as anti-virulence agent,
increasing susceptibility to host defense mechanisms such as
phagocytic clearance (Nizet 2015). A similar strategy is currently
exploited for S. aureus, where inhibition of the UDP-GlcNAc:lipid
phosphate transferase TarO is not detrimental to the bacterium,
but render the bacterium avirulent (Sewell and Brown 2014). An
additional effect of TarO inhibition is the re-sensitization of re-
sistant bacteria to β-lactam antibiotics due to an interaction be-
tween the WTA and peptidoglycan biosynthesis pathways in S.
aureus (Campbell et al. 2011). Similar synergymay occur between
conventional antibiotics and inhibitors of the RhaCWP pathway.
RhaCWP are also attractive vaccine candidates due to their
conserved and constant expression in species of medical im-
portance, such as S. pyogenes and S. agalactiae. Indeed, differ-
ent strategies are currently explored to develop protective vac-
cines against these streptococcal species (Dale et al. 2013; Steer,
Dale and Carapetis 2013; Nuccitelli, Rinaudo and Maione 2015).
For both pathogens, much research has focused on type-speciic
vaccine strategies, i.e. a capsule-conjugate vaccine for S. agalac-
tiae (Johri et al. 2006; Nuccitelli, Rinaudo and Maione 2015) and
a multivalent M-protein vaccine for S. pyogenes (Dale et al. 2013;
Steer, Dale and Carapetis 2013). A more elegant and globally ef-
fective approach would employ a vaccine antigen that is univer-
sally expressed on all strains in an invariant manner. Indeed,
the GBC is immunogenic in rabbits but antibodies raised are
not protective in a newborn mouse model (Marques et al. 1994),
likely due to shielding of the GBC by the polysaccharide capsule.
More encouraging are the results with regard to the GAC as a
universal S. pyogenes vaccine antigen. Conjugate vaccines of ei-
ther isolated or synthetic GAC protect mice from subsequent in-
fection after active and passive immunization (Sabharwal et al.
2006; Kabanova et al. 2010). However, there is controversy with
regards to safety in the use of the native GAC for vaccine pur-
poses, since several groups have indicated a role for anti-GlcNAc
antibodies in the pathogenesis of rheumatic fever (Goldstein
et al. 1968; Ayoub and Dudding 1970; Kirvan et al. 2003).
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Recent elucidation of the molecular pathway for GlcNAc side
chain formation allows for the development of an alternate vac-
cine antigen consisting of the polyrhamnose backbone of the
GAC (van Sorge et al. 2014). Anti-rhamnan antibodies raised
against the GlcNAc-deicient GAC enhanced phagocytic killing
of multiple M-serotypes in vitro and protected mice from lethal
challenge with wild-type S. pyogenes through passive immuniza-
tion (van Sorge et al. 2014). Of interest is the observation that
some streptococci also release RhaCWP into their surroundings.
Although it is unclear whether this involves an active mecha-
nism of release, it possibly has implications for the eficiency of
vaccine strategies. Overall, further exploration on the applica-
tion of RhaCWP for vaccination purposes is warranted.
Finally, dissection of the RhaCWP biosynthesis pathway
could beneit food production, most notably the dairy industry
that uses lactic acid bacteria for food fermentations (Chapot-
Chartier 2014). Phage infection of these fermenting cultures re-
sults in product variations but can also lead to huge economic
losses (Samson andMoineau 2013). The selection or engineering
of phage-resistant strains is therefore of considerable interest.
The role of RhaCWP in phage–host interaction has opened up
new possibilities for the development of bacteriophage insensi-
tive mutants for food production purposes. In addition to food
preparation, polysaccharides often have cosmetic, pharmaceu-
tical and biomedical applications. Elucidation of speciic trans-
ferase activities could be used towards metabolic engineering of
newmaterials or compoundswith interesting biological or phys-
ical properties. In particular, the incorporation of rare sugars
such as rhamnose and uronic acids is a rather unexplored area
but may be of interest to different areas including the biomedi-
cal ield (Roca et al. 2015).
CONCLUDING REMARKS
Despite their long history in streptococcal diagnostics, inves-
tigations on the biological roles and possible applications of
RhaCWP have lagged behind. Genome sequencing has initiated
genetic studies to elucidate structure–function relationships of
RhaCWP, highlighting their critical importance in proper cell
wall architecture and pathogenesis. Their indispensable nature
identiies the RhaCWP biosynthesis pathway as an attractive
therapeutic target for antimicrobial drug development. Spin offs
will likely ind applications in the area of metabolic engineering
for food production and biomedical purposes.
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